187 related articles for article (PubMed ID: 2449438)
1. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
Matsuura H; Takio K; Titani K; Greene T; Levery SB; Salyan ME; Hakomori S
J Biol Chem; 1988 Mar; 263(7):3314-22. PubMed ID: 2449438
[TBL] [Abstract][Full Text] [Related]
2. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin.
Matsuura H; Greene T; Hakomori S
J Biol Chem; 1989 Jun; 264(18):10472-6. PubMed ID: 2471705
[TBL] [Abstract][Full Text] [Related]
3. Synthetic immunochemistry of glycohexapeptide analogues characteristic of oncofetal fibronectin. Solid-phase synthesis and antigenic activity.
Zheng M; Gobbo M; Biondi L; Filira F; Hakomori S; Rocchi R
Int J Pept Protein Res; 1994 Mar; 43(3):230-8. PubMed ID: 8005745
[TBL] [Abstract][Full Text] [Related]
4. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
[TBL] [Abstract][Full Text] [Related]
5. Solution synthesis of the glyco-hexapeptide sequence of the human oncofetal fibronectin defined by monoclonal antibody FDC-6.
Gobbo M; Biondi L; Filira F; Rocchi R
Int J Pept Protein Res; 1991 Nov; 38(5):417-27. PubMed ID: 1724973
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site.
Feinberg RF; Kliman HJ; Bedian V; Monzon-Bordonaba F; Menzin AW; Wang CL
Am J Obstet Gynecol; 1995 May; 172(5):1526-36. PubMed ID: 7538728
[TBL] [Abstract][Full Text] [Related]
8. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
9. Efficient synthesis of O-linked glycopeptide by a transglycosylation using endo alpha-N-acetylgalactosaminidase from Streptomyces sp.
Ajisaka K; Miyasato M; Ishii-Karakasa I
Biosci Biotechnol Biochem; 2001 May; 65(5):1240-3. PubMed ID: 11440149
[TBL] [Abstract][Full Text] [Related]
10. Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody.
Matsushita T; Ohyabu N; Fujitani N; Naruchi K; Shimizu H; Hinou H; Nishimura S
Biochemistry; 2013 Jan; 52(2):402-14. PubMed ID: 23259747
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of an essential structure recognized by an anti-GalNAc alpha-Ser(Thr) monoclonal antibody (MLS 128).
Nakada H; Numata Y; Inoue M; Tanaka N; Kitagawa H; Funakoshi I; Fukui S; Yamashina I
J Biol Chem; 1991 Jul; 266(19):12402-5. PubMed ID: 1712019
[TBL] [Abstract][Full Text] [Related]
12. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
[TBL] [Abstract][Full Text] [Related]
13. UDPgalactose:glycoprotein-N-acetyl-D-galactosamine 3-beta-D-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates.
Granovsky M; Bielfeldt T; Peters S; Paulsen H; Meldal M; Brockhausen J; Brockhausen I
Eur J Biochem; 1994 May; 221(3):1039-46. PubMed ID: 8181460
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
[TBL] [Abstract][Full Text] [Related]
16. Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates.
Brockhausen I; Toki D; Brockhausen J; Peters S; Bielfeldt T; Kleen A; Paulsen H; Meldal M; Hagen F; Tabak LA
Glycoconj J; 1996 Oct; 13(5):849-56. PubMed ID: 8910012
[TBL] [Abstract][Full Text] [Related]
17. Identification and structural analysis of the tetrasaccharide NeuAc alpha(2-->6)Gal beta(1-->4)GlcNAc beta(1-->3)Fuc alpha 1-->O-linked to serine 61 of human factor IX.
Harris RJ; van Halbeek H; Glushka J; Basa LJ; Ling VT; Smith KJ; Spellman MW
Biochemistry; 1993 Jul; 32(26):6539-47. PubMed ID: 8329384
[TBL] [Abstract][Full Text] [Related]
18. Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.
Liu X; Sejbal J; Kotovych G; Koganty RR; Reddish MA; Jackson L; Gandhi SS; Mendonca AJ; Longenecker BM
Glycoconj J; 1995 Oct; 12(5):607-17. PubMed ID: 8595249
[TBL] [Abstract][Full Text] [Related]
19. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
20. Solid phase synthesis of the fibronectin glycopeptide V(Gal beta 3GalNAc alpha)THPGY, its beta analogue, and the corresponding unglycosylated peptide.
Lüning B; Norberg T; Rivera-Baeza C; Tejbrant J
Glycoconj J; 1991 Dec; 8(6):450-5. PubMed ID: 1823621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
